State Of Wyoming Kodiak Sciences Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $4,777 - $8,987	-948 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.09 - $89.45 $1,134 - $14,312	160 Added 20.3%	948 $7,000
Q4 2021 Feb 11, 2022	SELL	$80.85 - $128.49 $1,051 - $1,670	-13 Reduced 1.62%	788 $67,000
Q3 2021 Feb 11, 2022	SELL	$81.97 - $106.94 $29,755 - $38,819	-363 Reduced 31.19%	801 $77,000
Q2 2021 Feb 11, 2022	BUY	$77.2 - $126.54 $47,555 - $77,948	616 Added 112.41%	1,164 $108,000
Q1 2021 Feb 08, 2022	BUY	$110.45 - $164.47 $60,526 - $90,129	548 New	548 $62,000

109

40.9M

28.4K

21.2K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $202M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.